- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04094987
Interfascial Pressure Into Ultrasound Guided Anterior Quadratus Lumborum Block Application
Investigation of the Effect of Interfacial Pressure on Block Success During Anterior Quadratus Lumborum Block Application
The block has been shown to be the result of abdominal analgesia as a result of application between the quadratus lumborum (QL) muscle and the leaves in the thoracolumbar fascia.
In this block, local anesthetic drugs are administered between the quadratus lumborum (QL) muscle and the anterior leaf in the thoracolumbar fascia.
In this way, it has been reported that it provides a good analgesia as it relieves somatic pain better in upper and lower abdominal surgeries.
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bursa, Turkey
- University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Patients who were in the American Society of Anesthesiologists (ASA) I-III class
• Underwent laparoscopic cholecystectomy
Exclusion Criteria:
- Previous history of preoperative opioid use,
- Allergy to local anesthetics,
- The presence of any systemic infection,
- Uncontrolled arterial hypertension,
- Uncontrolled diabetes mellitus
- Presence of infection in the block area,
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Quadratus Lumborum block
We will use the ultrasound guided anterior Quadratus Lumborum Block.A peripheral nerve block catheter will be placed between the quadratus lumborum muscle and the psoas muscle with ultrasound
|
The pressure between the fascia and the pressure line added to the catheter tip will be measured.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interfascial Pressure (mm/hg)
Time Frame: 24 hours.
|
İnterfascial pressure will be measured the postoperative 24.
hours through catheter.
|
24 hours.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale
Time Frame: Postoperative 24 hours
|
Visual Analog Scale was used for pain.Pain intensity was measured using 0-10 cm visual analogue scale (VAS).
(0=no pain, 10=intolerable pain)
|
Postoperative 24 hours
|
|
analgesic use
Time Frame: Postoperative 24 hours
|
analgesic use
|
Postoperative 24 hours
|
|
sensory block level
Time Frame: peroperative 3 hours
|
After the application, the sensory block level at the 30 minutes after the block application and 30 minutes after the operation will be determined by cold test.
|
peroperative 3 hours
|
Collaborators and Investigators
Investigators
- Principal Investigator: Korgün Ökmen, University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2011-KAEK-25 2019/05-26
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.